Case and Research Letters
Dermatomyositis-Like Eruption Associated With Hydroxyurea Therapy: A Premalignant Condition?
Erupción dermatomiositis-like asociada al tratamiento con hidroxiurea: ¿una entidad premaligna?
Read
7058
Timeswas read the article
2131
Total PDF
4927
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 126 | 32 | 158 |
| 2025 5 | 186 | 32 | 218 |
| 2025 4 | 157 | 47 | 204 |
| 2025 3 | 159 | 21 | 180 |
| 2025 2 | 147 | 23 | 170 |
| 2025 1 | 96 | 34 | 130 |
| 2024 12 | 150 | 30 | 180 |
| 2024 11 | 101 | 61 | 162 |
| 2024 10 | 95 | 42 | 137 |
| 2024 9 | 102 | 29 | 131 |
| 2024 8 | 125 | 58 | 183 |
| 2024 7 | 92 | 38 | 130 |
| 2024 6 | 81 | 30 | 111 |
| 2024 5 | 80 | 33 | 113 |
| 2024 4 | 60 | 30 | 90 |
| 2024 3 | 74 | 32 | 106 |
| 2024 2 | 67 | 39 | 106 |
| 2024 1 | 62 | 34 | 96 |
| 2023 12 | 73 | 18 | 91 |
| 2023 11 | 70 | 25 | 95 |
| 2023 10 | 90 | 22 | 112 |
| 2023 9 | 75 | 23 | 98 |
| 2023 8 | 68 | 14 | 82 |
| 2023 7 | 81 | 43 | 124 |
| 2023 6 | 84 | 25 | 109 |
| 2023 5 | 93 | 26 | 119 |
| 2023 4 | 60 | 21 | 81 |
| 2023 3 | 70 | 28 | 98 |
| 2023 2 | 43 | 16 | 59 |
| 2023 1 | 51 | 25 | 76 |
| 2022 12 | 63 | 47 | 110 |
| 2022 11 | 40 | 29 | 69 |
| 2022 10 | 29 | 16 | 45 |
| 2022 9 | 26 | 41 | 67 |
| 2022 8 | 46 | 32 | 78 |
| 2022 7 | 32 | 33 | 65 |
| 2022 6 | 35 | 31 | 66 |
| 2022 5 | 43 | 35 | 78 |
| 2022 4 | 45 | 29 | 74 |
| 2022 3 | 54 | 44 | 98 |
| 2022 2 | 44 | 27 | 71 |
| 2022 1 | 48 | 32 | 80 |
| 2021 12 | 38 | 39 | 77 |
| 2021 11 | 48 | 43 | 91 |
| 2021 10 | 35 | 48 | 83 |
| 2021 9 | 35 | 39 | 74 |
| 2021 8 | 24 | 19 | 43 |
| 2021 7 | 31 | 28 | 59 |
| 2021 6 | 22 | 23 | 45 |
| 2021 5 | 31 | 26 | 57 |
| 2021 4 | 75 | 78 | 153 |
| 2021 3 | 42 | 9 | 51 |
| 2021 2 | 47 | 31 | 78 |
| 2021 1 | 17 | 13 | 30 |
| 2020 12 | 39 | 13 | 52 |
| 2020 11 | 19 | 14 | 33 |
| 2020 10 | 18 | 10 | 28 |
| 2020 9 | 36 | 21 | 57 |
| 2020 8 | 24 | 14 | 38 |
| 2020 7 | 23 | 8 | 31 |
| 2020 6 | 26 | 20 | 46 |
| 2020 5 | 26 | 26 | 52 |
| 2020 4 | 24 | 13 | 37 |
| 2020 3 | 28 | 14 | 42 |
| 2020 2 | 5 | 0 | 5 |
| 2020 1 | 5 | 1 | 6 |
| 2019 12 | 9 | 5 | 14 |
| 2019 11 | 4 | 2 | 6 |
| 2019 10 | 0 | 1 | 1 |
| 2019 9 | 4 | 1 | 5 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 4 | 0 | 4 |
| 2019 6 | 3 | 6 | 9 |
| 2019 5 | 6 | 9 | 15 |
| 2019 4 | 2 | 8 | 10 |
| 2019 3 | 2 | 4 | 6 |
| 2019 2 | 5 | 0 | 5 |
| 2019 1 | 2 | 0 | 2 |
| 2018 11 | 4 | 0 | 4 |
| 2018 10 | 4 | 0 | 4 |
| 2018 9 | 1 | 0 | 1 |
| 2018 2 | 42 | 3 | 45 |
| 2018 1 | 30 | 6 | 36 |
| 2017 12 | 46 | 7 | 53 |
| 2017 11 | 32 | 7 | 39 |
| 2017 10 | 22 | 6 | 28 |
| 2017 9 | 28 | 8 | 36 |
| 2017 8 | 42 | 4 | 46 |
| 2017 7 | 21 | 4 | 25 |
| 2017 6 | 44 | 13 | 57 |
| 2017 5 | 34 | 3 | 37 |
| 2017 4 | 38 | 11 | 49 |
| 2017 3 | 19 | 8 | 27 |
| 2017 2 | 18 | 7 | 25 |
| 2017 1 | 20 | 10 | 30 |
| 2016 12 | 32 | 18 | 50 |
| 2016 11 | 51 | 20 | 71 |
| 2016 10 | 37 | 13 | 50 |
| 2016 9 | 0 | 6 | 6 |
| 2016 7 | 13 | 2 | 15 |
| 2016 6 | 13 | 3 | 16 |
| 2016 5 | 13 | 2 | 15 |
| 2016 4 | 3 | 1 | 4 |
| 2016 3 | 5 | 0 | 5 |
| 2016 2 | 10 | 1 | 11 |
| 2016 1 | 9 | 0 | 9 |
| 2015 12 | 14 | 1 | 15 |
| 2015 11 | 12 | 1 | 13 |
| 2015 10 | 19 | 0 | 19 |
| 2015 9 | 9 | 1 | 10 |
| 2015 8 | 13 | 2 | 15 |
| 2015 7 | 29 | 4 | 33 |
| 2015 6 | 28 | 6 | 34 |
| 2015 5 | 24 | 15 | 39 |
| 2015 4 | 10 | 9 | 19 |
| 2015 3 | 24 | 8 | 32 |
| 2015 2 | 10 | 5 | 15 |
| 2015 1 | 5 | 2 | 7 |
| 2014 12 | 7 | 1 | 8 |
| 2014 11 | 6 | 0 | 6 |
Show all
